Table 2.
ART-Experienced (n = 330) N (%) |
Newly diagnosed with HIV (n = 1515) N (%) |
Total (n = 1845) N (%) |
P value | |
---|---|---|---|---|
Opportunistic infections at diagnosis of AHD | 58 (17.6) | 587 (38.8) | 645 (35.0) | <.001 |
TB | 19 (32.8) | 222 (37.8) | 241 (37.4) | .447 |
Chronic diarrhea | 4 (6.9) | 188 (32.0) | 192 (29.8) | <.001 |
Pneumocystis jirovecii | 5 (8.6) | 89 (15.2) | 94 (14.9) | .175 |
Kaposi Sarcoma | 2 (3.5) | 14 (2.4) | 16 (2.5) | .625 |
Cryptococcal Meningitis | 3 (5.2) | 8 (1.4) | 11 (1.7) | .035 |
Other* | 27 (46.6) | 291 (49.6) | 318 (49.3) | .663 |
Hospitalization at time AHD diagnosis | 3 (1.0) | 1 (0.1) | 4 (0.2) |
This table shows different opportunistic infections at AHD diagnosis and hospitalization experience, stratified by ART-experienced and newly-diagnosed clients. Participants may have had more than 1 opportunistic infection, ranging from 1 to 6, accounting for the percentage being above 100.
AHD = Advanced HIV disease, OI = opportunistic infections, TB = Tuberculosis.
Other (includes non-WHO stage III/IV): oral thrush (197), herpes simplex (77), vaginitis (38), toxoplasmosis (3), mycobacterium avian complex (2), Non-Hodgkin’s Lymphoma (1).